Adenoviral Delivery of the VEGF and BMP-6 Genes to Rat Mesenchymal Stem Cells Potentiates OsteogenesisReport as inadecuate




Adenoviral Delivery of the VEGF and BMP-6 Genes to Rat Mesenchymal Stem Cells Potentiates Osteogenesis - Download this document for free, or read online. Document in PDF available to download.

Bone Marrow ResearchVolume 2013 2013, Article ID 737580, 9 pages

Research ArticleOrthopaedic Research Laboratories, Department of Orthopedic Surgery, University of Virginia School of Medicine, P.O. Box 800159, Charlottesville, VA 22908, USA

Received 29 October 2012; Accepted 18 December 2012

Academic Editor: Peter J. Quesenberry

Copyright © 2013 Jesse Seamon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The combined delivery of mesenchymal stem cells MSCs, vascular endothelial growth factor VEGF, and bone morphogenetic protein BMP to sites of bone injury results in enhanced repair compared to the administration of a single factor or a combination of two factors. Based on these findings, we hypothesized that coexpression of VEGF and BMP-6 genes would enhance the osteoblastic differentiation of rat bone-marrow-derived stem cells rMSCs and osteogenesis by comparison to rMSCs that do not express VEGF and BMP-6. We prepared a GFP tagged adenovirus vector Ad-VEGF+BMP-6 that contained DNA encoding the hVEGF and hBMP-6 genes. rMSCs were transduced with the virus, and the successful transduction was confirmed by green fluorescence and by production of VEGF and BMP-6 proteins. The cells were cultured to assess osteoblastic differentiation or administered in the Fischer 344 rats to assess bone formation. Mineralization of rMSCs transduced with Ad-VEGF+BMP-6 was significantly enhanced over the nontransduced rMSCs. Only transduced rMSCs could induce osteogenesis in vivo, whereas Ad-VEGF+BMP-6 or nontransduced rMSCs alone did not induce osteogenesis. The data suggests that the combined delivery of MSCs, VEGF, and BMP-6 is an attractive option for bone repair therapy.





Author: Jesse Seamon, Xiuli Wang, Fuai Cui, Tom Keller, Abhijit S. Dighe, Gary Balian, and Quanjun Cui

Source: https://www.hindawi.com/



DOWNLOAD PDF




Related documents